PAKT

• Research type

  Research Study

• Full title

  A Phase II, randomised, placebo-controlled study of paclitaxel in combination with the AKT inhibitor AZD5363 in triple-negative advanced or metastatic breast cancer

• IRAS ID

  126381

• Contact name

  Peter Schmid

• Contact email

  p.schmid@qmul.ac.uk

• Sponsor organisation

  Queen Mary, University of London

• Eudract number

  2013-001521-43

• ISRCTN Number

  n/a

• REC name

  London - Hampstead Research Ethics Committee

• REC reference

  14/LO/0121

• Date of REC Opinion

  6 Feb 2014

• REC opinion

  Further Information Favourable Opinion